WO2008122723A3 - Utilisation d'acides gras polyinsatures et de flavonoïdes en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des migraines - Google Patents

Utilisation d'acides gras polyinsatures et de flavonoïdes en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des migraines Download PDF

Info

Publication number
WO2008122723A3
WO2008122723A3 PCT/FR2008/000254 FR2008000254W WO2008122723A3 WO 2008122723 A3 WO2008122723 A3 WO 2008122723A3 FR 2008000254 W FR2008000254 W FR 2008000254W WO 2008122723 A3 WO2008122723 A3 WO 2008122723A3
Authority
WO
WIPO (PCT)
Prior art keywords
flavonoids
poly
preventing
composition
fatty acids
Prior art date
Application number
PCT/FR2008/000254
Other languages
English (en)
Other versions
WO2008122723A2 (fr
Inventor
Jean-Christophe Anton
Denis Marin
Serge Sonie
Original Assignee
Persee Medica
Jean-Christophe Anton
Denis Marin
Serge Sonie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Persee Medica, Jean-Christophe Anton, Denis Marin, Serge Sonie filed Critical Persee Medica
Publication of WO2008122723A2 publication Critical patent/WO2008122723A2/fr
Publication of WO2008122723A3 publication Critical patent/WO2008122723A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention se rapporte à l'utilisation d'acides gras polyinsaturés et de flavonoïdes en tant qu'agents actifs pour une utilisation simultanée, séquentielle ou séparée pour la préparation d'une composition destinée à la prévention et/ou au traitement des céphalées.
PCT/FR2008/000254 2007-02-27 2008-02-27 Utilisation d'acides gras polyinsatures et de flavonoïdes en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des migraines WO2008122723A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0753519 2007-02-27
FR0753519A FR2912918A1 (fr) 2007-02-27 2007-02-27 Utilisation d'acides gras polyinsatures et de flavonoides en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des cephalees.

Publications (2)

Publication Number Publication Date
WO2008122723A2 WO2008122723A2 (fr) 2008-10-16
WO2008122723A3 true WO2008122723A3 (fr) 2009-01-22

Family

ID=38544168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000254 WO2008122723A2 (fr) 2007-02-27 2008-02-27 Utilisation d'acides gras polyinsatures et de flavonoïdes en tant qu'agents actifs dans une composition pour la prevention et/ou le traitement des migraines

Country Status (2)

Country Link
FR (1) FR2912918A1 (fr)
WO (1) WO2008122723A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948025B1 (fr) * 2009-07-15 2013-01-11 Univ Grenoble 1 Composition comprenant un polyphenol et un acide gras omega-3

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275643A1 (fr) * 1986-11-26 1988-07-27 Bar Ilan University Composition physiologiquement active et alimentaire
WO2002030404A2 (fr) * 2000-10-12 2002-04-18 Bioriginal Food & Science Corporation Therapie combinee destinee aux symptomes premenstruels
EP1198995A1 (fr) * 2000-10-17 2002-04-24 Laboratoires Robert Schwartz Composition anti-stress destinée à être incorporée principalement à des véhicules nutritionnels
JP2003055216A (ja) * 2001-08-03 2003-02-26 Nisshin Oillio Ltd 月経中症状緩和剤及びそれを含有する飲食物
DE10315025A1 (de) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0275643A1 (fr) * 1986-11-26 1988-07-27 Bar Ilan University Composition physiologiquement active et alimentaire
WO2002030404A2 (fr) * 2000-10-12 2002-04-18 Bioriginal Food & Science Corporation Therapie combinee destinee aux symptomes premenstruels
EP1198995A1 (fr) * 2000-10-17 2002-04-24 Laboratoires Robert Schwartz Composition anti-stress destinée à être incorporée principalement à des véhicules nutritionnels
JP2003055216A (ja) * 2001-08-03 2003-02-26 Nisshin Oillio Ltd 月経中症状緩和剤及びそれを含有する飲食物
DE10315025A1 (de) * 2003-04-02 2004-10-14 Bioplanta Arzneimittel Gmbh Wirkstoffkombination von ω3-fettsäurehaltigen Ölen mit polyphenolhaltigen Pflanzenextrakten und deren Verwendung

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ANTHONY M: "INDIVIDUAL FREE FATTY ACIDS AND MIGRAINE", CLINICAL AND EXPERIMENTAL NEUROLOGY, ADIS PRESS, NEW YORK, NY, US, vol. 15, 1978, pages 190 - 196, XP008038724, ISSN: 0196-6383 *
COOK N C ET AL: "Flavonoids-Chemistry, metabolism, cardioprotective effects, and dietary sources", JOURNAL OF NUTRITIONAL BIOCHEMISTRY, BUTTERWORTH PUBLISHERS, STONEHAM, GB, vol. 7, no. 2, February 1996 (1996-02-01), pages 66 - 76, XP004559815, ISSN: 0955-2863 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2004, CALLAWAY J C: "Hempseed as a nutritional resource: An overview", XP002454473, Database accession no. PREV200500204243 *
DATABASE WPI Section Ch Week 200337, Derwent World Patents Index; Class B05, AN 2003-385426, XP002454475 *
DUTOT G: "Rationnel du developpement d'une nouvelle emulsion lipidique : ClinOleic<(>R)", NUTRITION CLINIQUE ET METABOLISME, ARNETTE EDITIONS, PARIS, FR, vol. 10, no. 4, 1996, pages 11S - 14S, XP004884770, ISSN: 0985-0562 *
EUPHYTICA, vol. 140, no. 1-2, 2004, pages 65 - 72, ISSN: 0014-2336 *
ZANOLI ET AL: "New insight in the neuropharmacological activity of Humulus lupulus L", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER SCIENTIFIC PUBLISHERS LTD, IE, vol. 102, no. 1, 31 October 2005 (2005-10-31), pages 102 - 106, XP005091358, ISSN: 0378-8741 *

Also Published As

Publication number Publication date
FR2912918A1 (fr) 2008-08-29
WO2008122723A2 (fr) 2008-10-16

Similar Documents

Publication Publication Date Title
WO2008089087A3 (fr) Composition de type comprimé-dans-comprimé
WO2007095316A3 (fr) Compositions et procédés pour formulations à base d&#39;oligonucléotides
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
WO2010069532A8 (fr) Anticorps dirigés contre l&#39;angiopoïétine 2 humaine
AP2011005777A0 (en) Methods and compositions related to thioesterase enzymes.
IL213718A (en) An immunogenic preparation comprising at least two saccharides individually attached to the same type of carrier and compound @ comprising @ the preparation @ the B @ L
WO2009074735A3 (fr) Utilisation d&#39;un nouvel agent naturel dans des compositions cosmetiques
EP2020863A4 (fr) Compositions de confiserie contenant des ingrédients réactifs
WO2008085221A3 (fr) Utilisation thérapeutique de cellules exprimant cd31
EP1841404A4 (fr) Composition ameliorant l&#39;etat de la peau comprenant un extrait de vaccinium uliginosum et procede de preparation de celle-ci
WO2011017502A3 (fr) Formulations comprenant du linaclotide
WO2008007244A3 (fr) Compositions pour améliorer la santé oculaire
WO2010092088A3 (fr) Utilisation d&#39;hydrophobine en tant qu&#39;agent mouillant
WO2010072787A3 (fr) Composition et méthode de traitement d&#39;états pathologiques cutanés
WO2007124102A3 (fr) Préparation et utilisation de compositions contenant de la phlorizine
WO2012002730A3 (fr) Composition hydratante et de blanchiment de la peau contenant des extraits de venin d&#39;abeille
WO2008031940A3 (fr) Composition a base de xanthoxyline et son utilisation en cosmetique.
IL205350A0 (en) Novel 1, 3- dihydro - 5 - isobenzofurancarbonitrile derivatives and pharmacetical composition thereof for the treatment of premature ejaculation
EP1845941A4 (fr) Composition de sirop contenant du dexibupropene en tant que principe actif et son procede de preparation
WO2009080838A3 (fr) Confiseries à mâcher
WO2006103638A3 (fr) Compositions pharmaceutiques topiques de terbinafine et processus de preparation desdites compositions
WO2008071897A3 (fr) Utilisation topique d&#39;au moins un acide gras mono-insature pour ameliorer la chevelure
EP2260855A4 (fr) Composition contenant un extrait aqueux de feuilles d&#39;ashwagandha en tant que principe actif et procédé de production associé
WO2010061935A3 (fr) Composition et méthode de lutte contre les maladies végétales
WO2007080525A3 (fr) Composition à base de plante

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08775604

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08775604

Country of ref document: EP

Kind code of ref document: A2